Page last updated: 2024-08-24

imiquimod and Contact Dermatitis

imiquimod has been researched along with Contact Dermatitis in 18 studies

Research

Studies (18)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (16.67)	29.6817
2010's	11 (61.11)	24.3611
2020's	4 (22.22)	2.80

Authors

Authors	Studies
Díaz-Guimaraens, B; Dominguez-Santas, M; Hermosa-Gelbard, Á; Moreno-Arrones, ÓM; Saceda-Corralo, D; Suarez-Valle, A; Vañó-Galván, S	1
Choi, CW; Kang, JS; Kim, BR; Kim, Y; Yang, S; Youn, SW	1
Fujimoto, M; Fujisawa, Y; Ichimura, Y; Ishitsuka, Y; Kubota, N; Mizuno, S; Nakamura, Y; Okiyama, N; Saito, A; Takahashi, S; Tanaka, R; Watanabe, R	1
Atenhan, A; Batra, R; Biedermann, T; Boehner, A; Eyerich, K; Eyerich, S; Franz, R; Garzorz-Stark, N; Groß, C; Groß, O; Haak, S; Jargosch, M; Krause, L; Lauffer, F; Mueller, NS; Roenneberg, S; Schmidt-Weber, CB; Theis, FJ; Thomas, J; Traidl-Hoffmann, C	1
Assil, S; Burggraaf, J; Feiss, G; Florencia, E; Klaassen, ES; Moerland, M; Prens, EP; Rijneveld, R; Rissmann, R; van der Kolk, T; van Doorn, MBA	1
Harada, K; Iwakura, Y; Nakae, S; Numata, T; Shimura, E; Sudo, K; Tsuboi, R; Yamaguchi, S; Yoshizaki, T	1
Cao, J; Chen, J; Chen, X; Fu, Y; Guo, L; Hu, J; Li, P; Li, W; Li, Y; Liu, L; Peng, J; Qiu, C; Qu, R; Vasilev, K; Wang, W; Zhao, Y; Zhou, G	1
Dong, X; Liu, M; Qin, X; Ren, S; Song, Y; Wang, Q; Zhang, B; Zhang, W; Zhang, Y; Zhao, C	1
Backer, RA; Brand, A; Clausen, BE; Diener, N; Jiang, A; Karram, K; Mellman, I; Stoitzner, P; Tripp, C; Zahner, SP	1
Honda, T; Kabashima, K; Malissen, B; Nakamizo, S; Nakamura, M; Ohmori, S; Sawada, Y; Sugita, K; Tokura, Y; Yoshiki, R; Yoshioka, H	1
Anderegg, U; Busch, M; Herbert, D; Janik, T; Saalbach, A; Simon, JC	1
Arora, N; Pandey-Rai, S; Shah, K	1
Chao, YH; Chen, DY; Chen, HH; Chung, TW; Li, YR; Lin, CC; Yang, DH	1
Bai, S; Hou, S; Liu, X; Zhang, Z	1
Brauner, S; Eidsmo, L; Gallais Serezal, I; Guerreiro-Cacais, AO; Jagodic, M; Lindahl, H; Martini, E; Nikamo, P; Olsson, T; Ståhle, M	1
Boon, L; Cornelissen, F; Florencia, E; Kant, M; Laman, JD; Lubberts, E; Mourits, S; Mus, AM; Prens, EP; van der Fits, L; Voerman, JS	1
Fishelevich, R; Gaspari, AA; Luzina, I; Miller, RL; Thatcher, TH; Tomai, MA	1
Amerio, P; Miller, RL; Sauder, DN; Shivji, GM; Suzuki, H; Tomai, MA; Toto, P; Wang, B	1

Trials

1 trial(s) available for imiquimod and Contact Dermatitis

Article	Year
Comprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug Development. Clinical and translational science, 2018, Volume: 11, Issue:6 Topics: Administration, Cutaneous; Adult; Dermatitis, Contact; Dose-Response Relationship, Drug; Drug Development; Healthy Volunteers; Humans; Imiquimod; Male; Severity of Illness Index; Skin; Water Loss, Insensible; Young Adult	2018

Article

Year

Comprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug Development.

Clinical and translational science, 2018, Volume: 11, Issue:6

Topics: Administration, Cutaneous; Adult; Dermatitis, Contact; Dose-Response Relationship, Drug; Drug Development; Healthy Volunteers; Humans; Imiquimod; Male; Severity of Illness Index; Skin; Water Loss, Insensible; Young Adult

2018

Other Studies

17 other study(ies) available for imiquimod and Contact Dermatitis

Article	Year
Imiquimod-enhanced immunotherapy with diphencyprone for patients with alopecia areata. Dermatologic therapy, 2022, Volume: 35, Issue:7 Topics: Adult; Alopecia Areata; Cyclopropanes; Dermatitis, Contact; Female; Hair; Humans; Imiquimod; Immunologic Factors; Immunotherapy; Male; Treatment Outcome	2022
Regulatory T cells suppress skin inflammation in the imiquimod-induced psoriasis-like mouse model. Journal of dermatological science, 2020, Volume: 98, Issue:3 Topics: Animals; Dermatitis, Contact; Disease Models, Animal; Humans; Imiquimod; Interleukin-2 Receptor alpha Subunit; Intraepithelial Lymphocytes; Lymphocyte Depletion; Mice; Psoriasis; Severity of Illness Index; Skin; T-Lymphocytes, Regulatory; Time Factors	2020
Differential Involvement of Programmed Cell Death Ligands in Skin Immune Responses. The Journal of investigative dermatology, 2022, Volume: 142, Issue:1 Topics: Animals; Antigen Presentation; B7-H1 Antigen; Calcitriol; Cells, Cultured; Cytokines; Dendritic Cells; Dermatitis, Atopic; Dermatitis, Contact; Dinitrofluorobenzene; Disease Models, Animal; Humans; Imiquimod; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Programmed Cell Death 1 Ligand 2 Protein; Psoriasis; Skin; Th1 Cells; Th17 Cells; Th2 Cells	2022
Toll-like receptor 7/8 agonists stimulate plasmacytoid dendritic cells to initiate T The Journal of allergy and clinical immunology, 2018, Volume: 141, Issue:4 Topics: Administration, Cutaneous; Adult; Aged; Biomarkers; Case-Control Studies; Dendritic Cells; Dermatitis, Contact; Female; Flow Cytometry; Humans; Imiquimod; Immunohistochemistry; Male; Middle Aged; Models, Biological; Psoriasis; Real-Time Polymerase Chain Reaction; Th17 Cells; Toll-Like Receptor 7; Toll-Like Receptor 8	2018
IL-36α is involved in hapten-specific T-cell induction, but not local inflammation, during contact hypersensitivity. Biochemical and biophysical research communications, 2018, 11-30, Volume: 506, Issue:3 Topics: Animals; Cell Movement; Dendritic Cells; Dermatitis; Dermatitis, Contact; Haptens; Imiquimod; Inflammation; Interleukin-1; Keratinocytes; Lymph Nodes; Mice, Inbred C57BL; Psoriasis; Skin; T-Lymphocytes	2018
Ghrelin protects against contact dermatitis and psoriasiform skin inflammation by antagonizing TNF-α/NF-κB signaling pathways. Scientific reports, 2019, 02-04, Volume: 9, Issue:1 Topics: Animals; Dermatitis, Contact; Disease Models, Animal; Fibroblasts; Gene Expression Regulation; Ghrelin; Humans; Imiquimod; Immune System Diseases; Inflammation; Mice; NF-kappa B; Oxazolone; Psoriasis; RAW 264.7 Cells; Signal Transduction; Skin; Tumor Necrosis Factor-alpha	2019
Imiquimod enhances DNFB mediated contact hypersensitivity in mice. International immunopharmacology, 2019, Volume: 72 Topics: Adjuvants, Immunologic; Administration, Topical; Animals; Cell Proliferation; Dendritic Cells; Dermatitis, Contact; Dinitrofluorobenzene; Female; Histamine; Imiquimod; Lymph Nodes; Mast Cells; Mice, Inbred C57BL; Spleen	2019
E-Cadherin is Dispensable to Maintain Langerhans Cells in the Epidermis. The Journal of investigative dermatology, 2020, Volume: 140, Issue:1 Topics: Animals; Cadherins; CD11c Antigen; Cell Differentiation; Cell Movement; Cell Shape; Cells, Cultured; Dermatitis, Contact; Disease Models, Animal; Epidermis; Homeostasis; Humans; Imiquimod; Langerhans Cells; Mice; Mice, Knockout; Psoriasis	2020
IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells. The Journal of investigative dermatology, 2014, Volume: 134, Issue:7 Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Dermatitis, Contact; Disease Models, Animal; Imiquimod; Interleukin-12; Interleukin-17; Interleukin-22; Interleukin-23 Subunit p19; Interleukins; Langerhans Cells; Lymph Nodes; Mice; Mice, Inbred C57BL; Organ Culture Techniques; Psoriasis; Receptors, Antigen, T-Cell, gamma-delta; Receptors, CCR6; RNA, Messenger; Skin; Transplantation Chimera	2014
Fibroblasts support migration of monocyte-derived dendritic cells by secretion of PGE2 and MMP-1. Experimental dermatology, 2015, Volume: 24, Issue:8 Topics: Aminoquinolines; Animals; Cell Culture Techniques; Cell Movement; Cells, Cultured; Cellular Microenvironment; Collagen Type I; Cyclooxygenase 2; Cytokines; Dendritic Cells; Dermatitis, Contact; Dinoprostone; Enzyme Induction; Fibroblasts; Humans; Imiquimod; Irritants; Lipopolysaccharides; Matrix Metalloproteinase 1; Matrix Metalloproteinase 13; Mice; Mice, Inbred C57BL; Monocytes; Picryl Chloride; Psoriasis; Stromal Cells	2015
Inhibition of imiquimod-induced psoriasis-like dermatitis in mice by herbal extracts from some Indian medicinal plants. Protoplasma, 2016, Volume: 253, Issue:2 Topics: Aloe; Aminoquinolines; Animals; Celastrus; Curcuma; Cytokines; Dermatitis, Contact; Drug Evaluation, Preclinical; Gene Expression; Imiquimod; Male; Mice; Plant Extracts; Plant Stems; Plants, Medicinal; Psoriasis; Skin; Tinospora	2016
Oral administration of acarbose ameliorates imiquimod-induced psoriasis-like dermatitis in a mouse model. International immunopharmacology, 2016, Volume: 33 Topics: Acarbose; Administration, Oral; Aminoquinolines; Animals; Cell Movement; Cytokines; Dermatitis, Contact; Disease Models, Animal; Humans; Imiquimod; Mice; Mice, Inbred BALB C; Neutrophils; Psoriasis; Receptors, Antigen, T-Cell, gamma-delta; Skin; T-Lymphocytes, Regulatory; Th17 Cells	2016
Influence of different types of contact hypersensitivity on imiquimod-induced psoriasis-like inflammation in mice. Molecular medicine reports, 2016, Volume: 14, Issue:1 Topics: Aminoquinolines; Animals; Biomarkers; Cytokines; Dermatitis, Contact; Disease Models, Animal; Female; Gene Expression; Imiquimod; Mice; Psoriasis; Skin; Th1 Cells; Th17 Cells; Th2 Cells	2016
IL-22 binding protein regulates murine skin inflammation. Experimental dermatology, 2017, Volume: 26, Issue:5 Topics: Aminoquinolines; Animals; Case-Control Studies; Dermatitis, Contact; Female; Humans; Imiquimod; Male; Mice; Oxazolone; Psoriasis; Receptors, Interleukin	2017
Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. Journal of immunology (Baltimore, Md. : 1950), 2009, May-01, Volume: 182, Issue:9 Topics: Aminoquinolines; Animals; Cell Differentiation; Cell Proliferation; Dermatitis, Contact; Disease Models, Animal; Humans; Imiquimod; Inflammation Mediators; Interleukin-17; Interleukin-23; Keratinocytes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Psoriasis; Receptors, Interleukin-17	2009
Topical imiquimod treatment prevents UV-light induced loss of contact hypersensitivity and immune tolerance. The Journal of investigative dermatology, 2006, Volume: 126, Issue:4 Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antibodies, Monoclonal; Dermatitis, Contact; Female; I-kappa B Proteins; Imiquimod; Immune Tolerance; Interferon-gamma; Interleukin-12; Langerhans Cells; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Skin; Toll-Like Receptor 7; Ultraviolet Rays	2006
Imiquimod, a topical immune response modifier, induces migration of Langerhans cells. The Journal of investigative dermatology, 2000, Volume: 114, Issue:1 Topics: Adenosine Triphosphatases; Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Animals; Antibody Formation; Cell Count; Cell Movement; Cytokines; Dermatitis, Contact; Epidermal Cells; Histocompatibility Antigens Class II; Imiquimod; Langerhans Cells; Mice; Mice, Inbred C57BL; RNA, Messenger; Up-Regulation	2000